• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负责针对黏膜和淋巴系统诺如病毒感染进行疫苗接种及清除感染的免疫机制。

Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.

作者信息

Chachu Karen A, LoBue Anna D, Strong David W, Baric Ralph S, Virgin Herbert W

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

出版信息

PLoS Pathog. 2008 Dec;4(12):e1000236. doi: 10.1371/journal.ppat.1000236. Epub 2008 Dec 12.

DOI:10.1371/journal.ppat.1000236
PMID:19079577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2587711/
Abstract

Two cardinal manifestations of viral immunity are efficient clearance of acute infection and the capacity to vaccinate against secondary viral exposure. For noroviruses, the contributions of T cells to viral clearance and vaccination have not been elucidated. We report here that both CD4 and CD8 T cells are required for efficient clearance of primary murine norovirus (MNV) infection from the intestine and intestinal lymph nodes. Further, long-lasting protective immunity was generated by oral live virus vaccination. Systemic vaccination with the MNV capsid protein also effectively protected against mucosal challenge, while vaccination with the capsid protein of the distantly related human Lordsdale virus provided partial protection. Fully effective vaccination required a broad immune response including CD4 T cells, CD8 T cells, and B cells, but the importance of specific immune cell types varied between the intestine and intestinal lymph nodes. Perforin, but not interferon gamma, was required for clearance of MNV infection by adoptively transferred T lymphocytes from vaccinated hosts. These studies prove the feasibility of both mucosal and systemic vaccination against mucosal norovirus infection, demonstrate tissue specificity of norovirus immune cells, and indicate that efficient vaccination strategies should induce potent CD4 and CD8 T cell responses.

摘要

病毒免疫的两个主要表现是有效清除急性感染以及针对二次病毒暴露进行疫苗接种的能力。对于诺如病毒,T细胞对病毒清除和疫苗接种的作用尚未阐明。我们在此报告,CD4和CD8 T细胞都是从小肠和肠淋巴结中有效清除原发性小鼠诺如病毒(MNV)感染所必需的。此外,口服活病毒疫苗可产生持久的保护性免疫。用MNV衣壳蛋白进行全身疫苗接种也能有效抵御黏膜攻击,而用远缘相关的人类洛兹代尔病毒的衣壳蛋白进行疫苗接种则提供部分保护。完全有效的疫苗接种需要包括CD4 T细胞、CD8 T细胞和B细胞在内的广泛免疫反应,但特定免疫细胞类型的重要性在小肠和肠淋巴结之间有所不同。过继转移自接种宿主的T淋巴细胞清除MNV感染需要穿孔素,而不是干扰素γ。这些研究证明了针对黏膜诺如病毒感染进行黏膜和全身疫苗接种的可行性,证明了诺如病毒免疫细胞的组织特异性,并表明有效的疫苗接种策略应诱导强大的CD4和CD8 T细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/40088722431a/ppat.1000236.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/0fd2d767fb01/ppat.1000236.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/a03463701cf7/ppat.1000236.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/e8b21f19ef73/ppat.1000236.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/6f0086f21501/ppat.1000236.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/21a97601cef6/ppat.1000236.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/63da6b24e619/ppat.1000236.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/40088722431a/ppat.1000236.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/0fd2d767fb01/ppat.1000236.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/a03463701cf7/ppat.1000236.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/e8b21f19ef73/ppat.1000236.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/6f0086f21501/ppat.1000236.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/21a97601cef6/ppat.1000236.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/63da6b24e619/ppat.1000236.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/2587711/40088722431a/ppat.1000236.g007.jpg

相似文献

1
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.负责针对黏膜和淋巴系统诺如病毒感染进行疫苗接种及清除感染的免疫机制。
PLoS Pathog. 2008 Dec;4(12):e1000236. doi: 10.1371/journal.ppat.1000236. Epub 2008 Dec 12.
2
Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.α病毒佐剂诺如病毒样颗粒疫苗:异源、体液和黏膜免疫反应可抵御鼠诺如病毒攻击。
J Virol. 2009 Apr;83(7):3212-27. doi: 10.1128/JVI.01650-08. Epub 2009 Jan 28.
3
Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.持续性肠道鼠诺如病毒感染与功能欠佳的病毒特异性 CD8 T 细胞应答有关。
J Virol. 2013 Jun;87(12):7015-31. doi: 10.1128/JVI.03389-12. Epub 2013 Apr 17.
4
Identification of cross-reactive norovirus CD4+ T cell epitopes.鉴定交叉反应性诺如病毒 CD4+ T 细胞表位。
J Virol. 2010 Sep;84(17):8530-8. doi: 10.1128/JVI.00727-10. Epub 2010 Jun 23.
5
Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.通过对簇内诺如病毒株的比较研究,鉴定诺如病毒保护性免疫的免疫和病毒相关性。
PLoS Pathog. 2013;9(9):e1003592. doi: 10.1371/journal.ppat.1003592. Epub 2013 Sep 5.
6
Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.鼻内接种P颗粒疫苗为无菌猪提供了针对人GII.4诺如病毒腹泻的部分交叉变异保护。
J Virol. 2014 Sep 1;88(17):9728-43. doi: 10.1128/JVI.01249-14. Epub 2014 Jun 11.
7
Antibody is critical for the clearance of murine norovirus infection.抗体对于清除小鼠诺如病毒感染至关重要。
J Virol. 2008 Jul;82(13):6610-7. doi: 10.1128/JVI.00141-08. Epub 2008 Apr 16.
8
Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.经鼻内给予表达诺如病毒衣壳蛋白的重组腺病毒可刺激小鼠产生特异性体液免疫、黏膜免疫和细胞免疫反应。
Vaccine. 2008 Jan 24;26(4):460-8. doi: 10.1016/j.vaccine.2007.11.039. Epub 2007 Dec 4.
9
Differentiation and Protective Capacity of Virus-Specific CD8 T Cells Suggest Murine Norovirus Persistence in an Immune-Privileged Enteric Niche.病毒特异性CD8 T细胞的分化与保护能力提示小鼠诺如病毒在免疫特权性肠道生态位中持续存在。
Immunity. 2017 Oct 17;47(4):723-738.e5. doi: 10.1016/j.immuni.2017.09.017. Epub 2017 Oct 11.
10
Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus.原发性高剂量鼠诺如病毒1感染无法抵御同源病毒的二次攻击。
J Virol. 2009 Jul;83(13):6963-8. doi: 10.1128/JVI.00284-09. Epub 2009 Apr 29.

引用本文的文献

1
Norovirus co-opts NINJ1 for selective protein secretion.诺如病毒利用NINJ1进行选择性蛋白质分泌。
Sci Adv. 2025 Feb 28;11(9):eadu7985. doi: 10.1126/sciadv.adu7985.
2
Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway.脂质纳米颗粒作为诺如病毒VLP疫苗的佐剂,通过TLR9和I型干扰素依赖性途径增强细胞免疫和体液免疫反应。
J Virol. 2024 Dec 17;98(12):e0169924. doi: 10.1128/jvi.01699-24. Epub 2024 Nov 4.
3
Intestinal tuft cell immune privilege enables norovirus persistence.

本文引用的文献

1
Norwalk virus shedding after experimental human infection.人类实验性感染后诺如病毒的排泄情况。
Emerg Infect Dis. 2008 Oct;14(10):1553-7. doi: 10.3201/eid1410.080117.
2
Antibody is critical for the clearance of murine norovirus infection.抗体对于清除小鼠诺如病毒感染至关重要。
J Virol. 2008 Jul;82(13):6610-7. doi: 10.1128/JVI.00141-08. Epub 2008 Apr 16.
3
Mechanisms of GII.4 norovirus persistence in human populations.GII.4型诺如病毒在人群中持续存在的机制。
肠簇状细胞免疫豁免使诺如病毒得以持续存在。
Sci Immunol. 2024 Mar 22;9(93):eadi7038. doi: 10.1126/sciimmunol.adi7038.
4
Genetic mapping reveals OCA-T1-dependent tuning of tuft cell differentiation and intestinal type 2 immunity.遗传图谱揭示了 OCA-T1 依赖性对簇状细胞分化和肠道 2 型免疫的调节。
Sci Immunol. 2023 May 12;8(83):eade5019. doi: 10.1126/sciimmunol.ade5019.
5
Impact of the Microbiota on Viral Infections.微生物群对病毒感染的影响。
Annu Rev Virol. 2023 Sep 29;10(1):371-395. doi: 10.1146/annurev-virology-111821-115754. Epub 2023 Apr 18.
6
Profiling of humoral immune responses to norovirus in children across Europe.在欧洲各地儿童中诺如病毒体液免疫应答的分析。
Sci Rep. 2022 Aug 22;12(1):14275. doi: 10.1038/s41598-022-18383-6.
7
Immunity to enteric viruses.肠道病毒免疫。
Immunity. 2022 May 10;55(5):800-818. doi: 10.1016/j.immuni.2022.04.007.
8
Norovirus: Facts and Reflections from Past, Present, and Future.诺如病毒:过去、现在和未来的事实与反思。
Viruses. 2021 Nov 30;13(12):2399. doi: 10.3390/v13122399.
9
Simvastatin Reduces Protection and Intestinal T Cell Responses Induced by a Norovirus P Particle Vaccine in Gnotobiotic Pigs.辛伐他汀降低了无菌仔猪中诺如病毒P颗粒疫苗诱导的保护作用和肠道T细胞反应。
Pathogens. 2021 Jul 1;10(7):829. doi: 10.3390/pathogens10070829.
10
The dark side of the gut: Virome-host interactions in intestinal homeostasis and disease.肠道的阴暗面:肠道病毒组与宿主的相互作用在肠道稳态和疾病中的作用。
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20201044.
PLoS Med. 2008 Feb;5(2):e31. doi: 10.1371/journal.pmed.0050031.
4
Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles.抗体中和的小鼠诺如病毒的结构以及与病毒样颗粒的意外差异。
J Virol. 2008 Mar;82(5):2079-88. doi: 10.1128/JVI.02200-07. Epub 2007 Dec 19.
5
Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus.无菌小牛感染人诺如病毒基因II.4-HS66株后的发病机制及免疫反应
J Virol. 2008 Feb;82(4):1777-86. doi: 10.1128/JVI.01347-07. Epub 2007 Nov 28.
6
A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.一种佐剂为免疫刺激复合物(ISCOM)或黏膜淋巴组织趋化因子(mLT)的人诺如病毒样颗粒疫苗,在悉生猪疾病模型中可诱导细胞因子和抗体反应,并对同源GII.4型人诺如病毒产生保护作用。
Vaccine. 2007 Dec 5;25(50):8448-59. doi: 10.1016/j.vaccine.2007.09.040. Epub 2007 Oct 5.
7
Norovirus activity--United States, 2006-2007.2006 - 2007年美国诺如病毒活动情况
MMWR Morb Mortal Wkly Rep. 2007 Aug 24;56(33):842-6.
8
Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence.尽管序列差异有限,但属于单一基因组群的鼠诺如病毒仍表现出生物学多样性。
J Virol. 2007 Oct;81(19):10460-73. doi: 10.1128/JVI.00783-07. Epub 2007 Jul 25.
9
Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain).无菌猪感染人诺如病毒II.4基因组(HS66株)后的细胞因子和抗体反应。
J Virol. 2007 Sep;81(17):9183-92. doi: 10.1128/JVI.00558-07. Epub 2007 Jun 20.
10
Feline calicivirus.猫杯状病毒
Vet Res. 2007 Mar-Apr;38(2):319-35. doi: 10.1051/vetres:2006056. Epub 2007 Feb 13.